Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities.
Haruki KobayashiKazushige WakudaTateaki NaitoNobuaki MamesayaShota OmoriAkira OnoHirotsugu KenmotsuHaruyasu MurakamiMasahiro EndoHideyuki HaradaYasuhiro GonToshiaki TakahashiPublished in: Radiation oncology (London, England) (2021)
ILAs were found to be a predictive factor for radiation pneumonitis in patients with LS-SCLC treated with chemoradiotherapy. Patients with LS-SCLC and ILAs who were treated with chemoradiotherapy had both the possibility of long-term survival and risk of radiation pneumonitis.